Integration of Patient-reported Outcomes Assessment Into Routine Care for Patients Receiving Residential Treatment for Alcohol And/or Substance Use Disorder

Overview

Journal J Addict Med

Specialty Psychiatry

Date 2021 Oct 7

PMID 34619714

Citations 1

Authors

Cameron M Yi

Andrew S Huhn

J Gregory Hobelmann

John Finnerty

Bernadette Solounias

Kelly E Dunn

Affiliations

Soon will be listed here.

Abstract

Background: More than 3 million individuals receive treatment for alcohol use disorder (AUD) and/or substance use disorder each year, yet there exists no standardized method for measuring patient success in treatment. Quantifying a more comprehensive assessment of treatment outcomes could identify the relative efficacy of different treatment strategies for individuals with AUD/substance use disorders, and help patients to identify, in advance, appropriate treatment options.

Methods: This study developed and embedded patient-reported outcome measures into the routine clinical operations of a residential treatment program. Surveys assessed demographics, drug use history, physical and mental health, and quality of life. Outcomes were assessed among participants at admission (n = 961) and in patients who completed the survey at time of discharge (n = 633).

Results: Past 30-day alcohol and/or opioid use at admission were correlated with worse self-reported physical and mental health, sleep, and quality of life, and greater negative affect and craving ( P s < 0.05). Previous history of treatment and/or withdrawal management were associated with worse self-reported physical and mental health, quality of life, and increased craving ( P s < 0.05). Physical and mental health improved across timepoints and was most pronounced when comparing persons receiving treatment for opioid use disorder versus AUD, wherein persons with opioid use disorder had worse physical health at all time points, and greater sleep disturbance and negative affect at discharge ( P s < 0.05).

Conclusions: It is feasible to embed patient outcome monitoring into routine clinic operations, which could be used in the future to tailor treatment plans.

Citing Articles

Assessing Whole-Person Outcomes During Routine Clinical Care: A Rapid Scoping Review.

Parr N, Young S, Nelson B Med Care. 2024; 62(12 Suppl 1):S34-S42.

PMID: 39514493 PMC: 11548827. DOI: 10.1097/MLR.0000000000002046.

References

Pasareanu A, Opsal A, Vederhus J, Kristensen O, Clausen T . Quality of life improved following in-patient substance use disorder treatment. Health Qual Life Outcomes. 2015; 13:35. PMC: 4364507. DOI: 10.1186/s12955-015-0231-7. View

Swendsen J, Conway K, Degenhardt L, Dierker L, Glantz M, Jin R . Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction. 2009; 104(8):1346-55. PMC: 2794245. DOI: 10.1111/j.1360-0443.2009.02622.x. View

Norman G . Likert scales, levels of measurement and the "laws" of statistics. Adv Health Sci Educ Theory Pract. 2010; 15(5):625-32. DOI: 10.1007/s10459-010-9222-y. View

Frost M, Bonomi A, Cappelleri J, Schunemann H, Moynihan T, Aaronson N . Applying quality-of-life data formally and systematically into clinical practice. Mayo Clin Proc. 2007; 82(10):1214-28. DOI: 10.4065/82.10.1214. View

Conn V, Taylor S, Abele P . Myocardial infarction survivors: age and gender differences in physical health, psychosocial state and regimen adherence. J Adv Nurs. 1991; 16(9):1026-34. DOI: 10.1111/j.1365-2648.1991.tb03362.x. View

Tiffany S, Wray J . The clinical significance of drug craving. Ann N Y Acad Sci. 2011; 1248:1-17. PMC: 4041083. DOI: 10.1111/j.1749-6632.2011.06298.x. View

Garnick D, Horgan C, Acevedo A, McCorry F, Weisner C . Performance measures for substance use disorders--what research is needed?. Addict Sci Clin Pract. 2012; 7:18. PMC: 3564737. DOI: 10.1186/1940-0640-7-18. View

Cacciola J, Alterman A, DePhilippis D, Drapkin M, Valadez Jr C, Fala N . Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2012; 44(3):256-63. PMC: 3602977. DOI: 10.1016/j.jsat.2012.07.013. View

Sullivan G, Artino Jr A . Analyzing and interpreting data from likert-type scales. J Grad Med Educ. 2014; 5(4):541-2. PMC: 3886444. DOI: 10.4300/JGME-5-4-18. View

10.

Butler S, Budman S, McGee M, Davis M, Cornelli R, Morey L . Addiction severity assessment tool: development of a self-report measure for clients in substance abuse treatment. Drug Alcohol Depend. 2005; 80(3):349-60. DOI: 10.1016/j.drugalcdep.2005.05.005. View

11.

McLellan T . What is recovery? Revisiting the Betty Ford Institute Consensus Panel definition: The Betty Ford Consensus Panel and Consultants. J Subst Abuse Treat. 2009; 38(2):200-1. DOI: 10.1016/j.jsat.2009.11.002. View

12.

Gossop M, Marsden J, Stewart D, Rolfe A . Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend. 2000; 57(2):89-98. DOI: 10.1016/s0376-8716(99)00086-1. View

13.

Lohr K, Zebrack B . Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res. 2008; 18(1):99-107. DOI: 10.1007/s11136-008-9413-7. View

14.

Ciraulo D, Piechniczek-Buczek J, Iscan E . Outcome predictors in substance use disorders. Psychiatr Clin North Am. 2003; 26(2):381-409. DOI: 10.1016/s0193-953x(02)00106-5. View

15.

Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P . The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1999; 93(12):1857-67. DOI: 10.1046/j.1360-0443.1998.9312185711.x. View

16.

Dassow P . Measuring performance in primary care: what patient outcome indicators do physicians value?. J Am Board Fam Med. 2007; 20(1):1-8. DOI: 10.3122/jabfm.2007.01.060082. View

17.

Mircioiu C, Atkinson J . A Comparison of Parametric and Non-Parametric Methods Applied to a Likert Scale. Pharmacy (Basel). 2017; 5(2). PMC: 5597151. DOI: 10.3390/pharmacy5020026. View

18.

Edwards A, Ohlsson H, Sundquist J, Sundquist K, Kendler K . Socioeconomic sequelae of drug abuse in a Swedish national cohort. Drug Alcohol Depend. 2020; 212:107990. PMC: 7293925. DOI: 10.1016/j.drugalcdep.2020.107990. View

19.

Sayette M, Shiffman S, Tiffany S, Niaura R, Martin C, Shadel W . The measurement of drug craving. Addiction. 2000; 95 Suppl 2:S189-210. PMC: 2683662. DOI: 10.1080/09652140050111762. View

20.

Tiffany S, Friedman L, Greenfield S, Hasin D, Jackson R . Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2011; 107(4):709-18. PMC: 3257402. DOI: 10.1111/j.1360-0443.2011.03581.x. View